Prosecution Insights
Last updated: July 17, 2026
Application No. 18/407,660

DIPODAL SILANE BONDED SORBENTS FOR SOLID PHASE EXTRACTION AND USE THEREOF FOR OLIGONUCLEOTIDE EXTRACTION

Non-Final OA §102§103
Filed
Jan 09, 2024
Priority
Jan 11, 2023 — provisional 63/479,483
Examiner
PATEL, SMITA S
Art Unit
Tech Center
Assignee
WATERS TECHNOLOGIES Corporation
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
291 granted / 415 resolved
+10.1% vs TC avg
Strong +57% interview lift
Without
With
+57.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
17 currently pending
Career history
441
Total Applications
across all art units

Statute-Specific Performance

§103
86.4%
+46.4% vs TC avg
§102
4.1%
-35.9% vs TC avg
§112
4.5%
-35.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 415 resolved cases

Office Action

§102 §103
/DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This application is in response to preliminary amendment filed on 01/09/2024. Claims 1-5, 7-11, 16-25 are pending. Applicant has cancelled claims 6, 12-15 and 26-28. Applicant has elected Group I, Claims 1-5, 7-11 without traverse during telephone interview. Claims 16-25 are withdrawn as non-elected group claims. Election/Restriction 4. Restriction to one of the following inventions is required under 35 U.S.C. 121: I. Claims 1-5, 7-11 drawn to a sorbent material for performing solid phase extraction, classified in b01j20/103. II. Claims 16-25, drawn to a method for performing solid phase extraction, classified in G01N2030/8827. The inventions are independent or distinct, each from the other because: Inventions I and II are related as product and process of use. The inventions can be shown to be distinct if either or both of the following can be shown: (1) the process for using the product as claimed can be practiced with another materially different product or (2) the product as claimed can be used in a materially different process of using that product. See MPEP § 806.05(h). In the instant case, sorbent material can used for microchip separation or filtration membrane or microfluidic separation instead of solid phase extraction. Restriction for examination purposes as indicated is proper because all the inventions listed in this action are independent or distinct for the reasons given above and there would be a serious search and/or examination burden if restriction were not required because one or more of the following reasons apply: • the inventions have acquired a separate status in the art in view of their different classification, and/or • the inventions have acquired a separate status in the art due to their recognized divergent subject matter, and/or • the inventions require a different field of search (e.g., searching different classes /subclasses or electronic resources, or employing different search strategies or search queries). Applicant is advised that the reply to this requirement to be complete must include (i) an election of an invention to be examined even though the requirement may be traversed (37 CFR 1.143) and (ii) identification of the claims encompassing the elected invention. The election of an invention may be made with or without traverse. To reserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the restriction requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are added after the election, applicant must indicate which of these claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. Applicant is reminded that upon the cancellation of claims to a non-elected invention, the inventorship must be corrected in compliance with 37 CFR 1.48(a) if one or more of the currently named inventors is no longer an inventor of at least one claim remaining in the application. A request to correct inventorship under 37 CFR 1.48(a) must be accompanied by an application data sheet in accordance with 37 CFR 1.76 that identifies each inventor by his or her legal name and by the processing fee required under 37 CFR 1.17(i). The examiner has required restriction between product or apparatus claims and process claims. Where applicant elects claims directed to the product/apparatus, and all product/apparatus claims are subsequently found allowable, withdrawn process claims that include all the limitations of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined. In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined process claims will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with 37 CFR 1.104. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of 35 U.S.C. 101, 102, 103 and 112. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between product/apparatus claims and process claims may be maintained. Withdrawn process claims that are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See MPEP § 821.04. Additionally, in order for rejoinder to occur, applicant is advised that the process claims should be amended during prosecution to require the limitations of the product/apparatus claims. Failure to do so may result in no rejoinder. Further, note that the prohibition against double patenting rejections of 35 U.S.C. 121 does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See MPEP § 804.01. 5. A telephone call was made to Mr. Ricardo Joseph on 06/18/2026 to request an oral election to the above restriction requirement and applicant has elected Group I, Claims 1-5 and 7-11 without traverse. Group II claims will be withdrawn. 6. Applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, the allowable linking claim, such claim may be subject to provisional statutory and/or non-statutory double patenting rejections over the claims of the instant application. Where a restriction requirement is withdrawn, the provisions of 35 U.S.C. 121 are no longer applicable. In re Ziegler, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also MPEP § 804.01. Claim Objections 7. Claims 2-3 are objected to because of the following informalities: It is suggested to amend “the terminal” to “the at least two terminal” to ensure proper antecedent basis and to ensure consistency in the claim 2 line 1 and Claim 3 line 1. Appropriate correction is required. Claim Rejections - 35 USC § 102/103 8. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. 9. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 10. Claims 1-5 and 7-11 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Lauber et al (WO2019067637 A1, IDS cited reference by applicant). Regarding Claims 1-3, Lauber discloses high purity chromatographic material (HPCM) utilized in the method of solid phase extraction (page 24 lines 13-17 and page 38-lines 8-10) comprising a porous particles having average particle size of 0.3 to 100 um (page 10 lines 3-13, 27-29, overlaps claimed range of greater than 5 um and less than 100 um), wherein the surface of the porous particles comprising a hydrophobic surface group and one or more ionizable modifiers with proviso that when the ionizable modifier does not contain a Zwitterion, the ionizable modifier does not contain a quaternary ammonium moiety (i.e. reads on ligand, page 25 lines 1-5, page 28 lines 24-25) wherein the one or more ionizable modifier includes bis(3-trimethoxysilylpropyl)-N-methylamine (page 29 lines 20-21, reads on claims 1-3, also reads ligand that includes one or more bridging alkyl substituted amines and at least two terminal siloxyl groups with less than 16 carbon atoms of claim 1). As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claim 4, Lauber discloses hydrolytic stability over pH range from about 8.5 to 12 (see page 16 lines 23-27, page 10 lines 30-31). As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claim 5, Lauber discloses porous particles are porous silica particles (page 10 lines 7-12, examples) Regarding claim 7, Lauber discloses porous particles are porous silica/organic hybrid particles (page 25 lines 7-8, page 10 lines 7-13). Regarding claim 8, Lauber discloses porous particles having ligand surface concentration is less than 0.7 umol/m2 (page 32 lines 14-17). As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claim 9, Lauber discloses porous particles have an average pore diameter of between 20 to 1500 A (page 10 lines 25-26). Regarding claim 10, Lauber discloses one more bridging alkyl substituted amines comprises one or more pKa values less than 10.5 (i.e., pKa=10, page 33 lines 9-11). As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding Claim 11, Lauber discloses ligand with less than 12 carbon atoms (i.e., hydrophobic surface group and ionizable modifiers, page 16 lines 6-13, pages 27-29). Conclusion 11. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SMITA S PATEL whose telephone number is (571)270-5837. The examiner can normally be reached on 9AM-5PM EST M-W. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR). If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ching-Yiu Fung can be reached on 5712705713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SMITA S PATEL/Primary Examiner, Art Unit 1732 06/23/2026
Read full office action

Prosecution Timeline

Jan 09, 2024
Application Filed
Jun 26, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673897
HYDRAULIC BINDER COMPOSITION
4y 9m to grant Granted Jul 07, 2026
Patent 12662378
ALUMINUM OXYNITRIDE POWDER, DIRECT NITRIDATION HIGH-PRESSURE SYNTHESIS METHOD AND APPLICATION THEREOF
4y 7m to grant Granted Jun 23, 2026
Patent 12570770
AQUEOUS METHODS FOR TITANATING A CHROMIUM/SILICA CATALYST WITH AN ALKALI METAL
1y 0m to grant Granted Mar 10, 2026
Patent 12558681
METHOD FOR IMPROVING STABILITY OF CATALYST IN RECYCLING HFC-23
4y 7m to grant Granted Feb 24, 2026
Patent 12559376
METHODS AND SYSTEMS FOR PRODUCING ACTIVATED SILICATE BASED MATERIALS USING SUSTAINABLE ENERGY AND MATERIALS
4y 3m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
99%
With Interview (+57.1%)
3y 8m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 415 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month